Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

9 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
HIV drug resistance among adults initiating antiretroviral therapy in Uganda.
Watera C, Ssemwanga D, Namayanja G, Asio J, Lutalo T, Namale A, Sanyu G, Ssewanyana I, Gonzalez-Salazar JF, Nazziwa J, Nanyonjo M, Raizes E, Kabuga U, Mwangi C, Kirungi W, Musinguzi J, Mugagga K, Mbidde EK, Kaleebu P. Watera C, et al. Among authors: namayanja g. J Antimicrob Chemother. 2021 Aug 12;76(9):2407-2414. doi: 10.1093/jac/dkab159. J Antimicrob Chemother. 2021. PMID: 33993252 Free PMC article.
Prevalence of viral load suppression, predictors of virological failure and patterns of HIV drug resistance after 12 and 48 months on first-line antiretroviral therapy: a national cross-sectional survey in Uganda.
Ssemwanga D, Asio J, Watera C, Nannyonjo M, Nassolo F, Lunkuse S, Salazar-Gonzalez JF, Salazar MG, Sanyu G, Lutalo T, Kabuga U, Ssewanyana I, Namatovu F, Namayanja G, Namale A, Raizes E, Kaggwa M, Namuwenge N, Kirungi W, Katongole-Mbidde E, Kaleebu P; Uganda HIV Drug Resistance Technical Working Group. Ssemwanga D, et al. Among authors: namayanja g. J Antimicrob Chemother. 2020 May 1;75(5):1280-1289. doi: 10.1093/jac/dkz561. J Antimicrob Chemother. 2020. PMID: 32025714 Free PMC article.
HIV-1 drug resistance in antiretroviral-naive individuals in sub-Saharan Africa after rollout of antiretroviral therapy: a multicentre observational study.
Hamers RL, Wallis CL, Kityo C, Siwale M, Mandaliya K, Conradie F, Botes ME, Wellington M, Osibogun A, Sigaloff KC, Nankya I, Schuurman R, Wit FW, Stevens WS, van Vugt M, de Wit TF; PharmAccess African Studies to Evaluate Resistance (PASER). Hamers RL, et al. Lancet Infect Dis. 2011 Oct;11(10):750-9. doi: 10.1016/S1473-3099(11)70149-9. Epub 2011 Jul 27. Lancet Infect Dis. 2011. PMID: 21802367
Cohort profile: The PharmAccess African (PASER-M) and the TREAT Asia (TASER-M) monitoring studies to evaluate resistance--HIV drug resistance in sub-Saharan Africa and the Asia-Pacific.
Hamers RL, Oyomopito R, Kityo C, Phanuphak P, Siwale M, Sungkanuparph S, Conradie F, Kumarasamy N, Botes ME, Sirisanthana T, Abdallah S, Li PC, Ngorima N, Kantipong P, Osibogun A, Lee CK, Stevens WS, Kamarulzaman A, Derdelinckx I, Chen YM, Schuurman R, van Vugt M, Rinke de Wit TF; PharmAccess African PASER and TREAT Asia Studies to Evaluate Resistance. Hamers RL, et al. Int J Epidemiol. 2012 Feb;41(1):43-54. doi: 10.1093/ije/dyq192. Epub 2010 Nov 10. Int J Epidemiol. 2012. PMID: 21071386 Free PMC article. No abstract available.
Stevens - Johnson syndrome due to nevirapine.
Namayanja GK, Nankya JM, Byamugisha JK, Ssali FN, Kityo CM, Rwambuya SD, Mugerwa RD, Mmiro FA, Morrison CS, Salata RA. Namayanja GK, et al. Afr Health Sci. 2005 Dec;5(4):338-40. doi: 10.5555/afhs.2005.5.4.338. Afr Health Sci. 2005. PMID: 16615847 Free PMC article.
High viral suppression rates among PLHIV on dolutegravir who had an initial episode of viral non-suppression in Uganda September 2020-July 2021.
Namayanja GA, Da Silva JF, Elur B, Nasirumbi PM, Raizes E, Ssempiira J, Nazziwa E, Nabukenya M, Sewanyana I, Balaba J, Ntale J, Calnan J, Birabwa E, Akao J, Mwangi C, Naluguza M, Ahimbisibwe A, Katureebe C, Nabadda S, Nelson L, Dirlikov E. Namayanja GA, et al. PLoS One. 2024 Jun 26;19(6):e0305129. doi: 10.1371/journal.pone.0305129. eCollection 2024. PLoS One. 2024. PMID: 38923981 Free PMC article.
Scale-Up of HIV Antiretroviral Therapy and Estimation of Averted Infections and HIV-Related Deaths - Uganda, 2004-2022.
Dirlikov E, Kamoga J, Talisuna SA, Namusobya J, Kasozi DE, Akao J, Birabwa E, Ward JA, Elur B, Shiraishi RW, Corcoran C, Vasireddy V, Nelson R, Nelson LJ, Borgman M, Magongo EN, Kisaakye LN, Katureebe C, Kirungi W, Musinguzi J; PEPFAR Uganda. Dirlikov E, et al. MMWR Morb Mortal Wkly Rep. 2023 Jan 27;72(4):90-94. doi: 10.15585/mmwr.mm7204a2. MMWR Morb Mortal Wkly Rep. 2023. PMID: 36701255 Free PMC article.
Virological Response and Antiretroviral Drug Resistance Emerging during Antiretroviral Therapy at Three Treatment Centers in Uganda.
Kaleebu P, Kirungi W, Watera C, Asio J, Lyagoba F, Lutalo T, Kapaata AA, Nanyonga F, Parry CM, Magambo B, Nazziwa J, Nannyonjo M, Hughes P, Hladik W, Ruberantwari A, Namuwenge N, Musinguzi J, Downing R, Katongole-Mbidde E; HIV Drug Resistance Working group. Kaleebu P, et al. PLoS One. 2015 Dec 23;10(12):e0145536. doi: 10.1371/journal.pone.0145536. eCollection 2015. PLoS One. 2015. PMID: 26700639 Free PMC article.
Patterns of HIV-1 drug resistance after first-line antiretroviral therapy (ART) failure in 6 sub-Saharan African countries: implications for second-line ART strategies.
Hamers RL, Sigaloff KC, Wensing AM, Wallis CL, Kityo C, Siwale M, Mandaliya K, Ive P, Botes ME, Wellington M, Osibogun A, Stevens WS, Rinke de Wit TF, Schuurman R; PharmAccess African Studies to Evaluate Resistance (PASER). Hamers RL, et al. Clin Infect Dis. 2012 Jun;54(11):1660-9. doi: 10.1093/cid/cis254. Epub 2012 Apr 3. Clin Infect Dis. 2012. PMID: 22474222